Fatal neonatal hypertrophic cardiomyopathy caused by compound heterozygous truncating MYBPC3 mutation

Documenti analoghi

• Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene
  di: Deprez, R H Lekanne, et al.
  Pubblicazione: (2006)
• Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects
  di: Wessels, Marja W, et al.
  Pubblicazione: (2015)
• Haploinsufficiency of MYBPC3 Exacerbates the Development of Hypertrophic Cardiomyopathy in Heterozygous Mice
  di: Barefield, David, et al.
  Pubblicazione: (2014)
• MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy
  di: O’Lea ry, Thomas S., et al.
  Pubblicazione: (2018)
• Non-sustained ventricular tachycardias, conduction disorders and an impaired left ventricular ejection fraction in a 32-year-old woman
  di: Alsters, S., et al.
  Pubblicazione: (2019)